Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases.

COVID-19 SARS-CoV-2 pandemic disease-modifying therapies multiple sclerosis

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
16 Dec 2020
Historique:
received: 31 10 2020
revised: 08 12 2020
accepted: 15 12 2020
entrez: 19 12 2020
pubmed: 20 12 2020
medline: 20 12 2020
Statut: epublish

Résumé

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic is a challenge for all participants in the healthcare system. At the beginning of the pandemic, many physicians asked themselves what risk their patients, especially those with chronic diseases, were exposed to. We present an overview of all patients with multiple sclerosis (MS) and SARS-CoV-2 infection published in the literature so far. In total, there are publications on 873 SARS-CoV-2 positive MS patients and information on the outcome can be given for 700 patients. With regard to the different disease modifying therapies (DMTs), by far the most cases were described under anti-CD20 treatment (

Identifiants

pubmed: 33339436
pii: jcm9124067
doi: 10.3390/jcm9124067
pmc: PMC7766122
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Mult Scler Relat Disord. 2020 Jul;42:102204
pubmed: 32570203
J Allergy Clin Immunol. 2020 Jul;146(1):110-118
pubmed: 32294485
World J Clin Cases. 2020 Sep 6;8(17):3621-3644
pubmed: 32953841
Science. 2020 May 1;368(6490):473-474
pubmed: 32303591
Neurol Neuroimmunol Neuroinflamm. 2020 May 5;7(4):
pubmed: 32371550
Hematology. 2020 Dec;25(1):320
pubmed: 32783598
Mult Scler Relat Disord. 2020 Sep;44:102306
pubmed: 32585617
Mult Scler Relat Disord. 2020 Sep;44:102323
pubmed: 32593961
JAMA Neurol. 2020 Sep 1;77(9):1079-1088
pubmed: 32589189
J Neurol. 2020 Jul 11;:
pubmed: 32654064
J Neurol. 2020 Oct;267(10):2790-2796
pubmed: 32494856
Mult Scler Relat Disord. 2020 Jul;42:102196
pubmed: 32480326
J Neuroimmunol. 2020 Aug 15;345:577282
pubmed: 32505908
Mult Scler Relat Disord. 2020 Sep;44:102245
pubmed: 32512287
J Neurol Sci. 2020 Sep 15;416:117011
pubmed: 32650143
JAMA Netw Open. 2020 Jun 1;3(6):e2012270
pubmed: 32543702
Neurol Neuroimmunol Neuroinflamm. 2020 Jul 9;7(5):
pubmed: 32646885
Mult Scler Relat Disord. 2020 Sep;44:102314
pubmed: 32593959
Int J Antimicrob Agents. 2020 May;55(5):105954
pubmed: 32234467
Mult Scler Relat Disord. 2020 Jul;42:102182
pubmed: 32416330
BMC Public Health. 2018 May 2;18(1):574
pubmed: 29716568
Mult Scler J Exp Transl Clin. 2020 Aug 10;6(3):2055217320942931
pubmed: 32850133
Mult Scler Relat Disord. 2020 Oct;45:102392
pubmed: 32683306
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Mult Scler Relat Disord. 2020 Jun;41:102165
pubmed: 32388451
J Med Virol. 2020 Jul 9;:
pubmed: 32644205
Front Immunol. 2019 Sep 24;10:2275
pubmed: 31616438
Mult Scler. 2020 Sep;26(10):1268-1269
pubmed: 32463329
Mult Scler Relat Disord. 2020 Oct;45:102402
pubmed: 32711297
Mult Scler Relat Disord. 2020 Oct;45:102442
pubmed: 32777745
Mult Scler. 2020 Sep;26(10):1264-1266
pubmed: 32762488
Pathogens. 2020 Mar 04;9(3):
pubmed: 32143502
Neurol Sci. 2020 Aug;41(8):1981-1983
pubmed: 32564270
Mult Scler Relat Disord. 2020 Oct;45:102437
pubmed: 32763844
Mult Scler Relat Disord. 2020 Jul;42:102192
pubmed: 32570202
Mult Scler Relat Disord. 2020 Nov;46:102482
pubmed: 32916509
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Mult Scler. 2020 Sep;26(10):1256-1260
pubmed: 32662742
Mult Scler Relat Disord. 2020 Oct;45:102338
pubmed: 32629402
Cell Immunol. 2018 Aug;330:86-90
pubmed: 29370889
Mol Med Rep. 2020 Jul;22(1):9-19
pubmed: 32377709
Mult Scler Relat Disord. 2020 Sep;44:102297
pubmed: 32554284
J Neurol. 2020 Aug 31;:
pubmed: 32865629
Mult Scler Relat Disord. 2020 Sep;44:102341
pubmed: 32622338
Mult Scler Relat Disord. 2020 Nov;46:102469
pubmed: 32919180
Mult Scler Relat Disord. 2020 Nov;46:102447
pubmed: 32835901
Mult Scler Relat Disord. 2020 Oct;45:102452
pubmed: 32823148
J Neurol. 2020 Oct;267(10):2803-2805
pubmed: 32494855
Respirology. 2003 Nov;8 Suppl:S36-40
pubmed: 15018132
Ann Rheum Dis. 2020 Dec;79(12):1544-1549
pubmed: 32796045
Neurol Neuroimmunol Neuroinflamm. 2020 May 26;7(5):
pubmed: 32457226
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Mult Scler Relat Disord. 2020 Jul;42:102163
pubmed: 32388458
Clin Immunol. 2020 Jun;215:108427
pubmed: 32325252
Mult Scler Relat Disord. 2020 Nov;46:102476
pubmed: 32882501
SN Compr Clin Med. 2020 Jun 25;:1-4
pubmed: 32838146
J Neuroimmunol. 2020 Jul 15;346:577323
pubmed: 32688146
Mol Med Rep. 2020 Jul;22(1):20-32
pubmed: 32319647
EBioMedicine. 2020 Jul;57:102833
pubmed: 32574956
Mult Scler Relat Disord. 2020 Sep;44:102250
pubmed: 32531754
Mult Scler Relat Disord. 2020 Jul;42:102201
pubmed: 32480327
Mult Scler. 2020 Sep;26(10):1261-1264
pubmed: 32762494
Nat Rev Immunol. 2020 Jun;20(6):351
pubmed: 32303696
J Infect Public Health. 2020 Sep;13(9):1202-1209
pubmed: 32718894
Dig Dis Sci. 2020 Oct 19;:
pubmed: 33073335
Mult Scler Relat Disord. 2020 Oct;45:102276
pubmed: 32652473
Mult Scler Relat Disord. 2020 Aug;43:102195
pubmed: 32460086
Mult Scler Relat Disord. 2020 Oct;45:102414
pubmed: 32711296
Mult Scler Relat Disord. 2020 Sep;44:102315
pubmed: 32593144
Front Immunol. 2020 May 12;11:1059
pubmed: 32477373
Mult Scler Relat Disord. 2020 Sep;44:102372
pubmed: 32650121
J Neurol. 2020 Jun 25;:
pubmed: 32588182
Int Immunopharmacol. 2020 Nov;88:106924
pubmed: 32877828
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Mult Scler Relat Disord. 2020 Aug;43:102222
pubmed: 32464586
Rev Neurol (Paris). 2020 Jun;176(6):523-525
pubmed: 32362357
Clin Chem. 2020 Apr 1;66(4):549-555
pubmed: 32031583
Mult Scler Relat Disord. 2020 Nov;46:102453
pubmed: 32835900
Mult Scler Relat Disord. 2020 Jul;42:102185
pubmed: 32408147
Nat Rev Rheumatol. 2020 Aug;16(8):413-414
pubmed: 32499548
Mult Scler Relat Disord. 2020 Jul;42:102180
pubmed: 32408155
Ann Rheum Dis. 2020 Nov;79(11):1393-1399
pubmed: 32769150
Front Immunol. 2020 May 29;11:1131
pubmed: 32574265
Mult Scler Relat Disord. 2020 Jul;42:102120
pubmed: 32315980

Auteurs

Nora Möhn (N)

Department of Neurology, Hanover Medical School, 30625 Hannover, Germany.

Franz F Konen (FF)

Department of Neurology, Hanover Medical School, 30625 Hannover, Germany.

Refik Pul (R)

Department of Neurology, University Hospital Essen, 45147 Essen, Germany.

Christoph Kleinschnitz (C)

Department of Neurology, University Hospital Essen, 45147 Essen, Germany.

Harald Prüss (H)

Department of Neurology and Experimental Neurology, Charité Universitätsmedizin Berlin and German Center for Neurodegenerative Diseases (DZNE), 10117 Berlin, Germany.

Torsten Witte (T)

Department of Rheumatology & Immunology, Hannover Medical School, 30625 Hannover, Germany.

Martin Stangel (M)

Department of Neurology, Hanover Medical School, 30625 Hannover, Germany.

Thomas Skripuletz (T)

Department of Neurology, Hanover Medical School, 30625 Hannover, Germany.

Classifications MeSH